Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""DIPHOSPHONATES"" wg kryterium: Temat


Starter badań:

Tytuł :
Inhibition of bacterial and human zinc-metalloproteases by bisphosphonate- and catechol-containing compounds.
Autorzy :
Rahman F; Department of Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway.
Nguyen TM; Department of Pharmacy, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway.
Adekoya OA; Department of Pharmacy, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway.
Campestre C; Department of Pharmacy, University of 'G. d'Annunzio' Chieti, Chieti, Italy.
Tortorella P; Department of Pharmacy, Science of Pharmacy, University 'A. Moro' Bari, Bari, Italy.
Sylte I; Department of Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway.
Winberg JO; Department of Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway.
Pokaż więcej
Źródło :
Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2021 Dec; Vol. 36 (1), pp. 819-830.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Bacterial Agents/*pharmacology
Catechols/*pharmacology
Diphosphonates/*pharmacology
Matrix Metalloproteinase Inhibitors/*pharmacology
Metalloendopeptidases/*antagonists & inhibitors
Anti-Bacterial Agents/chemical synthesis ; Anti-Bacterial Agents/chemistry ; Bacteria/enzymology ; Catechols/chemical synthesis ; Catechols/chemistry ; Diphosphonates/chemical synthesis ; Diphosphonates/chemistry ; Humans ; Matrix Metalloproteinase Inhibitors/chemical synthesis ; Matrix Metalloproteinase Inhibitors/chemistry ; Metalloendopeptidases/metabolism ; Microbial Sensitivity Tests ; Models, Molecular ; Molecular Structure ; THP-1 Cells
Czasopismo naukowe
Tytuł :
Osteoporosis, bisphosphonate use, and risk of moderate or worse hearing loss in women.
Autorzy :
Curhan SG; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Stankovic K; Harvard Medical School, Boston, Massachusetts, USA.; Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Boston, Massachusetts, USA.
Halpin C; Department of Otolaryngology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Wang M; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.
Eavey RD; Vanderbilt Bill Wilkerson Center for Otolaryngology and Communication Sciences, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Paik JM; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, Massachusetts, USA.
Curhan GC; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.; Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
Journal of the American Geriatrics Society [J Am Geriatr Soc] 2021 Nov; Vol. 69 (11), pp. 3103-3113. Date of Electronic Publication: 2021 May 24.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Diphosphonates*/adverse effects
Diphosphonates*/therapeutic use
Hearing/*drug effects
Hearing Loss/*epidemiology
Osteoporosis/*drug therapy
Adult ; Aged ; Audiometry/instrumentation ; Cohort Studies ; Female ; Hearing/physiology ; Humans ; Longitudinal Studies ; Middle Aged ; Risk Factors ; Self Report ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid.
Autorzy :
Li JW; Discipline of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China.
Wang JY; Discipline of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China.
Yu RQ; Discipline of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China.
Huo L; Department of Orthodontics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Zheng LW; Discipline of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China. .
Pokaż więcej
Źródło :
BMC research notes [BMC Res Notes] 2022 Jan 10; Vol. 15 (1), pp. 12. Date of Electronic Publication: 2022 Jan 10.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Density Conservation Agents*
Diphosphonates*
Animals ; Femur ; Rats ; Tooth Extraction ; Zoledronic Acid
Czasopismo naukowe
Tytuł :
Detection and residence time of bisphosphonates in bone of horses.
Autorzy :
Knych HK; K.L. Maddy Equine Analytical Pharmacology Laboratory, University of California, Davis, CA, USA.
Janes J; University of Kentucky Veterinary Diagnostic Laboratory, Lexington, KY, USA.
Kennedy L; University of Kentucky Veterinary Diagnostic Laboratory, Lexington, KY, USA.
McKemie DS; K.L. Maddy Equine Analytical Pharmacology Laboratory, University of California, Davis, CA, USA.
Arthur RM; School of Veterinary Medicine, University of California, Davis, CA, USA.
Samol MA; California Animal Health and Food Safety Laboratory, San Bernardino Laboratory, University of California, Davis, CA, USA.
Uzal FA; California Animal Health and Food Safety Laboratory, San Bernardino Laboratory, University of California, Davis, CA, USA.
Scollay M; Kentucky Horse Racing Commission, Lexington, KY, USA.
Pokaż więcej
Źródło :
Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc [J Vet Diagn Invest] 2022 Jan; Vol. 34 (1), pp. 23-27.
Typ publikacji :
Journal Article
MeSH Terms :
Diphosphonates*
Tandem Mass Spectrometry*/veterinary
Animals ; Chromatography, Liquid/veterinary ; Horses
Czasopismo naukowe
Tytuł :
The optimized drug delivery systems of treating cancer bone metastatic osteolysis with nanomaterials.
Autorzy :
Cheng X; Department of Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
Wei J; Department of Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
Ge Q; Department of Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
Xing D; Department of Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
Zhou X; State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, People's Republic of China.
Qian Y; Center of Stomatology, The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
Jiang G; Department of Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
Pokaż więcej
Źródło :
Drug delivery [Drug Deliv] 2021 Dec; Vol. 28 (1), pp. 37-53.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antineoplastic Agents/*administration & dosage
Bone Neoplasms/*drug therapy
Diphosphonates/*administration & dosage
Nanostructures/*chemistry
Osteolysis/*drug therapy
Osteolysis/*pathology
Antineoplastic Agents/adverse effects ; Biocompatible Materials ; Bone Neoplasms/secondary ; Delayed-Action Preparations ; Diphosphonates/adverse effects ; Drug Carriers/chemistry ; Drugs, Chinese Herbal/administration & dosage ; Genetic Therapy/methods ; Humans ; Hydrogels/administration & dosage ; Osteoclasts/metabolism ; Osteogenesis/physiology ; Phototherapy/methods ; Tissue Scaffolds
Czasopismo naukowe
Tytuł :
Tiludronic acid can be detected in blood and urine samples from Thoroughbred racehorses over 3 years after last administration.
Autorzy :
Riggs CM; Veterinary Clinical Services, The Hong Kong Jockey Club, Sha Tin Racecourse, Hong Kong SAR, China.
Thompson SL; Veterinary Clinical Services, The Hong Kong Jockey Club, Sha Tin Racecourse, Hong Kong SAR, China.
So YM; Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Hong Kong SAR, China.
Wong JKY; Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Hong Kong SAR, China.
Wan TSM; Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Hong Kong SAR, China.
Robinson P; Veterinary Clinical Services, The Hong Kong Jockey Club, Sha Tin Racecourse, Hong Kong SAR, China.
Stewart BD; Veterinary Regulation, Welfare and Biosecurity Policy, The Hong Kong Jockey Club, Sha Tin Racecourse, Hong Kong SAR, China.
Ho ENM; Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Hong Kong SAR, China.
Pokaż więcej
Źródło :
Equine veterinary journal [Equine Vet J] 2021 Nov; Vol. 53 (6), pp. 1287-1295. Date of Electronic Publication: 2020 Dec 23.
Typ publikacji :
Journal Article
MeSH Terms :
Diphosphonates*
Animals ; Chromatography, High Pressure Liquid/veterinary ; Horses ; Mass Spectrometry/veterinary ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Polyethylenimine-Bisphosphonate-Cyclodextrin Ternary Conjugates: Supramolecular Systems for the Delivery of Antineoplastic Drugs.
Autorzy :
Plesselova S; Department of Biochemistry and Molecular Biology II, School of Pharmacy, University of Granada, E-18071 Granada, Spain.; Unit of Excellence in Chemistry Applied to Biomedicine and the Environment of the University of Granada, E-18071 Granada, Spain.
Garcia-Cerezo P; Department of Organic Chemistry, School of Sciences, University of Granada, E-18071 Granada, Spain.; Unit of Excellence in Chemistry Applied to Biomedicine and the Environment of the University of Granada, E-18071 Granada, Spain.
Blanco V; Department of Organic Chemistry, School of Sciences, University of Granada, E-18071 Granada, Spain.; Unit of Excellence in Chemistry Applied to Biomedicine and the Environment of the University of Granada, E-18071 Granada, Spain.
Reche-Perez FJ; Department of Biochemistry and Molecular Biology II, School of Pharmacy, University of Granada, E-18071 Granada, Spain.; Unit of Excellence in Chemistry Applied to Biomedicine and the Environment of the University of Granada, E-18071 Granada, Spain.
Hernandez-Mateo F; Department of Organic Chemistry, School of Sciences, University of Granada, E-18071 Granada, Spain.; Biotechnology Institute, University of Granada, E-18071 Granada, Spain.; Unit of Excellence in Chemistry Applied to Biomedicine and the Environment of the University of Granada, E-18071 Granada, Spain.
Santoyo-Gonzalez F; Department of Organic Chemistry, School of Sciences, University of Granada, E-18071 Granada, Spain.; Biotechnology Institute, University of Granada, E-18071 Granada, Spain.; Unit of Excellence in Chemistry Applied to Biomedicine and the Environment of the University of Granada, E-18071 Granada, Spain.
Giron-Gonzalez MD; Department of Biochemistry and Molecular Biology II, School of Pharmacy, University of Granada, E-18071 Granada, Spain.; Unit of Excellence in Chemistry Applied to Biomedicine and the Environment of the University of Granada, E-18071 Granada, Spain.
Salto-Gonzalez R; Department of Biochemistry and Molecular Biology II, School of Pharmacy, University of Granada, E-18071 Granada, Spain.; Unit of Excellence in Chemistry Applied to Biomedicine and the Environment of the University of Granada, E-18071 Granada, Spain.
Pokaż więcej
Źródło :
Journal of medicinal chemistry [J Med Chem] 2021 Aug 26; Vol. 64 (16), pp. 12245-12260. Date of Electronic Publication: 2021 Aug 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Cyclodextrins/*chemistry
Diphosphonates/*chemistry
Drug Carriers/*chemistry
Neoplasms/*drug therapy
Polyethyleneimine/*analogs & derivatives
Animals ; Cell Line, Tumor ; Cyclodextrins/chemical synthesis ; Cyclodextrins/toxicity ; Diphosphonates/chemical synthesis ; Diphosphonates/toxicity ; Doxorubicin/therapeutic use ; Drug Carriers/chemical synthesis ; Drug Carriers/toxicity ; Drug Design ; Female ; Humans ; Mice ; Polyethyleneimine/chemical synthesis ; Polyethyleneimine/toxicity ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Impact of α-modifications on the activity of triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.
Autorzy :
Fairweather AER; Department of Chemistry, University of Iowa, Iowa City, IA 52242-1294, USA.
Goetz DB; Department of Chemistry, University of Iowa, Iowa City, IA 52242-1294, USA.
Schroeder CM; Department of Chemistry, University of Iowa, Iowa City, IA 52242-1294, USA.
Bhuiyan NH; Department of Chemistry, University of Iowa, Iowa City, IA 52242-1294, USA.
Varney ML; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Wiemer DF; Department of Chemistry, University of Iowa, Iowa City, IA 52242-1294, USA; Department of Pharmacology, University of Iowa, Iowa City, IA 52242-1109, USA.
Holstein SA; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA. Electronic address: .
Pokaż więcej
Źródło :
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2021 Aug 15; Vol. 44, pp. 116307. Date of Electronic Publication: 2021 Jul 11.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Diphosphonates/*pharmacology
Enzyme Inhibitors/*pharmacology
Farnesyltranstransferase/*antagonists & inhibitors
Triazoles/*pharmacology
Diphosphonates/chemical synthesis ; Diphosphonates/chemistry ; Dose-Response Relationship, Drug ; Enzyme Inhibitors/chemical synthesis ; Enzyme Inhibitors/chemistry ; Farnesyltranstransferase/metabolism ; Humans ; Molecular Structure ; Structure-Activity Relationship ; Triazoles/chemical synthesis ; Triazoles/chemistry
Czasopismo naukowe
Tytuł :
Response to: "Zoledronate-induced acute anterior uveitis: a three-case report and brief review of literature".
Autorzy :
Samalia P; Ophthalmology Department, Auckland District Health Board, Greenlane Clinical Centre, 214 Greenlane West, Epsom, Auckland, 1051, New Zealand. .
Niederer R; Ophthalmology Department, Auckland District Health Board, Greenlane Clinical Centre, 214 Greenlane West, Epsom, Auckland, 1051, New Zealand.; Department of Ophthalmology, University of Auckland, 85 Park Road, Grafton, Auckland, 1023, New Zealand.
Pokaż więcej
Źródło :
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2021 Oct; Vol. 32 (10), pp. 2139. Date of Electronic Publication: 2021 Aug 22.
Typ publikacji :
Letter; Comment
MeSH Terms :
Diphosphonates*/adverse effects
Uveitis, Anterior*/chemically induced
Humans ; Zoledronic Acid
Opinia redakcyjna
Tytuł :
BISPHOSPHONATE-INDUCED BILATERAL ANTERIOR UVEITIS AND CHOROIDAL EFFUSIONS WITH SECONDARY ANGLE CLOSURE.
Autorzy :
Thng ZX; Department of Ophthalmology, National Healthgroup Eye Institute, Tan Tock Seng Hospital, Singapore.
Li ZK
Gan NY
Pokaż więcej
Źródło :
Retinal cases & brief reports [Retin Cases Brief Rep] 2021 Sep 01; Vol. 15 (5), pp. 552-555.
Typ publikacji :
Case Reports
MeSH Terms :
Choroidal Effusions*/chemically induced
Diphosphonates*/adverse effects
Uveitis, Anterior*/chemically induced
Female ; Glaucoma, Angle-Closure ; Humans ; Middle Aged
Raport
Tytuł :
Bisphosphonate nephropathy: A case series and review of the literature.
Autorzy :
de Roij van Zuijdewijn C; Department of Internal Medicine, Spaarne Gasthuis, Haarlem/Hoofddorp, the Netherlands.; Department of Nephrology & Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
van Dorp W; Department of Internal Medicine, Spaarne Gasthuis, Haarlem/Hoofddorp, the Netherlands.
Florquin S; Department of Pathology & Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Roelofs J; Department of Pathology & Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Verburgh K; Department of Internal Medicine, Spaarne Gasthuis, Haarlem/Hoofddorp, the Netherlands.
Pokaż więcej
Źródło :
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Sep; Vol. 87 (9), pp. 3485-3491. Date of Electronic Publication: 2021 Mar 04.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Diphosphonates*/adverse effects
Kidney Diseases*
Animals ; Humans ; Imidazoles ; Pamidronate ; Rats ; Zoledronic Acid/adverse effects
Czasopismo naukowe
Tytuł :
Medication-Related Osteonecrosis of the Mandible.
Autorzy :
Omami G; Division of Oral Medicine, Diagnosis and Radiology, Department of Oral Health Practice, 160339University of Kentucky College of Dentistry, Lexington, KY, USA.
Pokaż więcej
Źródło :
Ear, nose, & throat journal [Ear Nose Throat J] 2021 Sep; Vol. 100 (8), pp. NP366-NP367. Date of Electronic Publication: 2020 Apr 13.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Diphosphonates/*adverse effects
Mandibular Diseases/*chemically induced
Osteonecrosis/*chemically induced
Administration, Intravenous ; Breast Neoplasms/drug therapy ; Breast Neoplasms/pathology ; Cone-Beam Computed Tomography ; Diphosphonates/administration & dosage ; Female ; Humans ; Magnetic Resonance Imaging ; Mandible/diagnostic imaging ; Mandibular Diseases/diagnostic imaging ; Middle Aged ; Neoplasm Metastasis ; Osteonecrosis/diagnostic imaging
Czasopismo naukowe
Tytuł :
Switching to Denosumab or Bisphosphonates After Completion of Teriparatide Treatment in Women With Severe Postmenopausal Osteoporosis.
Autorzy :
Kocjan T; Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia; Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. Electronic address: .
Rajic AS; Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Janez A; Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia; Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Vidmar G; Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia; University Rehabilitation Institute, Ljubljana, Slovenia; Department of Psychology, Faculty of Mathematics, Natural Sciences and Information Technologies, University of Primorska, Koper, Slovenia.
Orehek N; Chair of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
Marc J; Chair of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
Ostanek B; Chair of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
Pokaż więcej
Źródło :
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2021 Sep; Vol. 27 (9), pp. 941-947. Date of Electronic Publication: 2021 Jun 07.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Density Conservation Agents*/therapeutic use
Denosumab*/therapeutic use
Diphosphonates*/therapeutic use
Osteoporosis, Postmenopausal*/drug therapy
Aged ; Bone Density ; Drug Substitution ; Female ; Humans ; Retrospective Studies ; Teriparatide/therapeutic use
Czasopismo naukowe
Tytuł :
The Effect of Bisphosphonates on Fracture Healing Time and Changes in Bone Mass Density: A Meta-Analysis.
Autorzy :
Gao Y; Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
Liu X; Department Radiology, University of Toledo Medical Center, Toledo, OH, United States.
Gu Y; Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
Song D; Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
Ding M; Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
Liao L; Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
Wang J; Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
Ni J; Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
He G; Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
Pokaż więcej
Źródło :
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2021 Aug 30; Vol. 12, pp. 688269. Date of Electronic Publication: 2021 Aug 30 (Print Publication: 2021).
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Bone Density/*drug effects
Bone Density Conservation Agents/*administration & dosage
Diphosphonates/*administration & dosage
Fracture Healing/*drug effects
Osteoporosis/*drug therapy
Bone Density Conservation Agents/therapeutic use ; Bone Remodeling/drug effects ; Diphosphonates/therapeutic use ; Humans
Czasopismo naukowe
Tytuł :
Bisphosphonate Use and Hospitalization for Hip Fractures in Women: An Observational Population-Based Study in France.
Autorzy :
Bourrion B; Institut Pierre-Louis d'Epidémiologie et de Santé Publique (IPLESP UMRS 1136), INSERM, Sorbonne Université, 75012 Paris, France.; Département de Médecine Générale, Faculté des Sciences de la Santé Simone Veil, Université Versailles-Saint-Quentin-en-Yvelines, 78180 Montigny le Bretonneux, France.
Souty C; Institut Pierre-Louis d'Epidémiologie et de Santé Publique (IPLESP UMRS 1136), INSERM, Sorbonne Université, 75012 Paris, France.
Fournier L; Institut Pierre-Louis d'Epidémiologie et de Santé Publique (IPLESP UMRS 1136), INSERM, Sorbonne Université, 75012 Paris, France.
Vilcu AM; Institut Pierre-Louis d'Epidémiologie et de Santé Publique (IPLESP UMRS 1136), INSERM, Sorbonne Université, 75012 Paris, France.
Blanchon T; Institut Pierre-Louis d'Epidémiologie et de Santé Publique (IPLESP UMRS 1136), INSERM, Sorbonne Université, 75012 Paris, France.
Böelle PY; Institut Pierre-Louis d'Epidémiologie et de Santé Publique (IPLESP UMRS 1136), INSERM, Sorbonne Université, 75012 Paris, France.; Service de Santé Publique, Hôpital Universitaire Saint-Antoine, AP-HP, 75012 Paris, France.
Hanslik T; Institut Pierre-Louis d'Epidémiologie et de Santé Publique (IPLESP UMRS 1136), INSERM, Sorbonne Université, 75012 Paris, France.; Service de Médecine Interne, Hôpital Universitaire Ambroise-Paré, AP-HP, 92100 Boulogne-Billancourt, France.; Faculté des Sciences de la Santé Simone Veil, Université de Versailles Saint-Quentin-en-Yvelines, 78180 Montigny-le-Bretonneux, France.
François M; Institut Pierre-Louis d'Epidémiologie et de Santé Publique (IPLESP UMRS 1136), INSERM, Sorbonne Université, 75012 Paris, France.; Département de Médecine Générale, Faculté des Sciences de la Santé Simone Veil, Université Versailles-Saint-Quentin-en-Yvelines, 78180 Montigny le Bretonneux, France.; CESP, Bâtiment 15/16 Inserm, Hôpital Paul Brousse, 16 Avenue Paul Vaillant Couturier, INSERM, UVSQ, Université Paris-Saclay, 94807 Villejuif, France.
Pokaż więcej
Źródło :
International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Aug 20; Vol. 18 (16). Date of Electronic Publication: 2021 Aug 20.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Diphosphonates*/therapeutic use
Hip Fractures*/epidemiology
Hip Fractures*/prevention & control
Aged ; Female ; France/epidemiology ; Hospitalization ; Humans ; Middle Aged ; Prospective Studies
Czasopismo naukowe
Tytuł :
Effectiveness of bisphosphonates on bone mineral density in osteopenic postmenopausal women: A systematic review and network meta-analysis of randomized controlled trials.
Autorzy :
Dong SL; Affiliated Hospital of Hebei University of Engineering, Handan City, Hebei Province, China.
Jiao Y
Yang HL
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Aug 06; Vol. 100 (31), pp. e26715.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Bone Density/*drug effects
Diphosphonates/*standards
Bone Density Conservation Agents/pharmacology ; Bone Density Conservation Agents/standards ; Diphosphonates/pharmacology ; Humans ; Menopause/drug effects ; Menopause/physiology ; Network Meta-Analysis ; Randomized Controlled Trials as Topic/statistics & numerical data
Czasopismo naukowe
Tytuł :
Use of bisphosphonates in a retrospective case series of children and adolescents with complex regional pain syndrome.
Autorzy :
Walfish L; Faculty of Medicine, McGill University, Montreal, QC, Canada.
Sbrocchi AM; Department of Endocrinology, Montreal Children's Hospital, McGill University Health Center, Montreal, QC, Canada.
Rivera G; Chronic Pain Unit, Department of Anesthesia, Clínica Las Condes, Santiago, Chile.
Ricaurte Gracia YLN; School of Medicine, Fundación Universitaria de Ciencias de la Salud (FUCS), Bogotá, Colombia.
Mohamed N; Department of Pediatric Anesthesia, Edwards Family Interdisciplinary Centre for Chronic Pain, Montreal Children's Hospital, McGill University Health Center, Montreal, QC, Canada.
González Cárdenas VH; School of Medicine, Fundación Universitaria de Ciencias de la Salud (FUCS), Bogotá, Colombia.; Department of Anesthesia, Department of Anesthesia, Pain & Palliative Care, Los Cobos Medical Center, Hospital Universitario de la Samaritana, Bogotá, Colombia.
Stoopler M; Faculty of Medicine, McGill University, Montreal, QC, Canada.
Ingelmo P; Department of Pediatric Anesthesia, Edwards Family Interdisciplinary Centre for Chronic Pain, Montreal Children's Hospital, McGill University Health Center, Montreal, QC, Canada.; The Alan Edward Centre for Research on Pain, McGill University, Montreal, QC, Canada.
Pokaż więcej
Źródło :
Paediatric anaesthesia [Paediatr Anaesth] 2021 Aug; Vol. 31 (8), pp. 871-877. Date of Electronic Publication: 2021 Jun 03.
Typ publikacji :
Journal Article
MeSH Terms :
Complex Regional Pain Syndromes*/drug therapy
Diphosphonates*/therapeutic use
Adolescent ; Child ; Female ; Humans ; Infusions, Intravenous ; Injections, Intravenous ; Male ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Structure-activity relationships of pyrimidine nucleotides containing a 5'-α,β-methylene diphosphonate at the P2Y 6 receptor.
Autorzy :
Oliva P; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Scortichini M; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Dobelmann C; University of Münster, European Institute for Molecular Imaging (EIMI), Waldeyerstraße 15, D-48149 Münster, Germany.
Jain S; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Gopinatth V; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Toti KS; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Phung NB; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Junker A; University of Münster, European Institute for Molecular Imaging (EIMI), Waldeyerstraße 15, D-48149 Münster, Germany.
Jacobson KA; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: .
Pokaż więcej
Źródło :
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2021 Aug 01; Vol. 45, pp. 128137. Date of Electronic Publication: 2021 May 26.
Typ publikacji :
Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Diphosphonates/*pharmacology
Pyrimidine Nucleotides/*pharmacology
Receptors, Purinergic P2/*metabolism
Diphosphonates/chemistry ; Dose-Response Relationship, Drug ; Humans ; Molecular Structure ; Pyrimidine Nucleotides/chemical synthesis ; Pyrimidine Nucleotides/chemistry ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł :
Nonbisphosphonate inhibitors of Plasmodium falciparum FPPS/GGPPS.
Autorzy :
Kabeche S; Department of Biochemistry, Stanford Medical School, Stanford University, Stanford, CA 94305, USA.
Aida J; Research, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome Fujisawa, Kanagawa 251-8555, Japan.
Akther T; Research, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome Fujisawa, Kanagawa 251-8555, Japan.
Ichikawa T; Research, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome Fujisawa, Kanagawa 251-8555, Japan.
Ochida A; Research, Takeda Pharmaceutical Company Ltd, 26-1, Muraokahigashi 2-chome Fujisawa, Kanagawa 251-8555, Japan.
Pulkoski-Gross MJ; Department of Biochemistry, Stanford Medical School, Stanford University, Stanford, CA 94305, USA.
Smith M; Department of ChEM-H, Stanford University, Stanford, CA 94305, USA.
Humphries PS; Department of ChEM-H, Stanford University, Stanford, CA 94305, USA.
Yeh E; Department of Biochemistry, Stanford Medical School, Stanford University, Stanford, CA 94305, USA.
Pokaż więcej
Źródło :
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2021 Jun 01; Vol. 41, pp. 127978. Date of Electronic Publication: 2021 Mar 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antimalarials/*pharmacology
Diphosphonates/*pharmacology
Enzyme Inhibitors/*pharmacology
Farnesyltranstransferase/*antagonists & inhibitors
Geranyltranstransferase/*antagonists & inhibitors
Plasmodium falciparum/*drug effects
Antimalarials/chemical synthesis ; Antimalarials/chemistry ; Diphosphonates/chemical synthesis ; Diphosphonates/chemistry ; Dose-Response Relationship, Drug ; Enzyme Inhibitors/chemical synthesis ; Enzyme Inhibitors/chemistry ; Farnesyltranstransferase/metabolism ; Geranyltranstransferase/metabolism ; Molecular Structure ; Parasitic Sensitivity Tests ; Plasmodium falciparum/enzymology ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł :
Exploiting the anticancer effects of a nitrogen bisphosphonate nanomedicine for glioblastoma multiforme.
Autorzy :
Jena LN; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.
Bennie LA; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.
McErlean EM; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.
Pentlavalli S; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.
Glass K; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.
Burrows JF; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.
Kett VL; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.
Buckley NE; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.
Coulter JA; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.
Dunne NJ; School of Mechanical and Manufacturing Engineering, Dublin City University, Dublin 9, Ireland.; Centre for Medical Engineering Research, School of Mechanical and Manufacturing Engineering, Dublin City University, Dublin 9, Ireland.; Department of Mechanical and Manufacturing Engineering, School of Engineering, Trinity College Dublin, Dublin 2, Ireland.; Advanced Manufacturing Research Centre (I-Form), School of Mechanical and Manufacturing Engineering, Dublin City University, Glasnevin, Dublin 9, Ireland.; Advanced Materials and Bioengineering Research Centre (AMBER), Royal College of Surgeons in Ireland and Trinity College Dublin, Dublin, Ireland.; Advanced Processing Technology Research Centre, Dublin City University, Dublin 9, Ireland.; Trinity Centre for Biomedical Engineering, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.
McCarthy HO; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK. .; School of Chemical Sciences, Dublin City University, Dublin 9, Ireland. .
Pokaż więcej
Źródło :
Journal of nanobiotechnology [J Nanobiotechnology] 2021 May 04; Vol. 19 (1), pp. 127. Date of Electronic Publication: 2021 May 04.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents/*pharmacology
Diphosphonates/*pharmacology
Glioblastoma/*drug therapy
Nanomedicine/*methods
Nitrogen/*pharmacology
Alendronate/chemistry ; Alendronate/pharmacology ; Alendronate/therapeutic use ; Animals ; Apoptosis/drug effects ; Brain Neoplasms ; Cell Line, Tumor ; Cell Survival/drug effects ; Diphosphonates/chemistry ; Diphosphonates/therapeutic use ; Humans ; Nanoparticles/chemistry ; Particle Size ; Peptides
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies